Pfizer 5. Mai 2026 Pfizer’s $2.3B Trillium bet ends in failure as remaining CD47 blocker scrapped along with T-cell engager - Fierce Biotech
Pfizer 5. Mai 2026 FDA approves Pfizer and Arvina’s breast cancer drug despite weak clinical data - medwatch.com
Pfizer 4. Mai 2026 Pfizer vs Moderna: Only One Pharma Giant Is a Winner In The Post-Covid Era - Yahoo Finance
Pfizer 1. Mai 2026 FDA hands Pfizer, Arvinas’ Veppanu early approval for breast cancer subtype - Fierce Pharma
Pfizer 29. Apr. 2026 Pfizer looks to jump start Elrexfio with topline win in second-line myeloma - Fierce Pharma
Pfizer 28. Apr. 2026 Pfizer’s victory in delaying Vyndamax generics is mixed bag for BridgeBio: analysts - Fierce Pharma
Pfizer 28. Apr. 2026 BofA raises BridgeBio Pharma stock price target on Pfizer settlement clarity - Investing.com
Pfizer 28. Apr. 2026 Pfizer deals extend patent life for a top-selling rare disease drug - BioPharma Dive